Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (3): 304-310.doi: 10.3736/jcim20080317

• Literature Review • Previous Articles     Next Articles

Application of quality of life scale in evaluating the efficacy of gastric cancer treatment

Jun Zheng1, Jian Zheng1, Pei-yong Zheng2()   

  1. 1. Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    2. Clinical Research Assessment Center, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2007-09-06 Online:2008-03-20 Published:2008-03-15
  • Contact: PY Zheng E-mail:ZPYChina@sina.com

CLC Number: 

  • R735.2

"

第一作者 国家 诊断 研究内容 病例数 QOL量表(类型) 评价结果
Gockel[24] 德国 胃癌 比较胃全切除术和胃次全切除术后的QOL 73例 GIQLI(消化道普适性) 胃次全切除术患者的QOL改善
Hoksch[25] 德国 胃癌 评价胃癌不同方式消化道重建术(有无贮袋重建以及重建贮袋的大小)后的QOL 41例 QOL-C30和食物消耗量表(普适性和自制特异性) QOL无明显不同,但是15 cm贮袋重建术式健康状况较好
Horváth[26] 匈牙利 胃癌胃全切
除术后
比较Roux-en-Y吻合术与对口空肠贮袋式吻合术的QOL差异 46例 GIQLI(消化道普适性) 对口空肠贮袋式吻合术的QOL改善
Huang[27] 中国
台湾
胃癌 比较胃全切术和胃次全切术的QOL 51例 QLQ-C30和QLQ-STO22(普适性和特异性) 胃次全切除术的QOL优于全胃切除术
Bae[28] 韩国 I~III期胃癌 比较胃全切术和胃次全切术的QOL 391例 QLQ-C30和QLQ-STO22(普适性和特异性) 胃次全切术的患者QOL改善
刘统成[29] 中国 胃癌 探讨不同的胃癌根治术式对QOL的影响 89例 Spitzer生活质量指数及Chew-wun Wu特殊症状量表(普适性和特异性) 不同术式QOL无显著差异;清扫淋巴结范围越大,QOL越差
马增山[30] 中国 III期贲门癌 比较胃次全切除与全胃切除术后的QOL 268例 参照Karnofsky评分标准自制量表(普适性) 近期QOL全胃切除术略高,远期则相反
Kono[31] 日本 早期胃癌 全胃切除术后空肠贮袋重建对QOL的影响 47例 胃肠道症状积分量表(普适性) 空肠贮袋重建有利于QOL改善
Shiraishi[32] 日本 早期胃癌 胃癌切除术+胃管重建或空肠吻合术或Roux-en-Y吻合术后的QOL 51例 Korenaga 24项问卷(自制特异性) 胃癌切除术+胃管重建术获得更好的QOL

"

第一作者 国家 诊断 研究内容 病例数 QOL量表(类型) 评价结果
Díaz De Lia?o[35] 西班牙 胃癌 扩大淋巴结清扫是否有益于患者QOL提高 54例 QLQ-C30和自制胃癌模块(普适性和特异性) 总QOL未受到影响,社交方面QOL改善
Blazeby[36] 英国 胃癌和
食管癌
评价术后远期疗效和QOL的关系 130例 QLQ-C30(普适性) QOL能够预测手术受益率
陈于平[37] 中国 贲门腺
探讨贲门腺癌切除术后患者远期生存的QOL 96例 SF-36量表(普适性) 手术治疗有利于QOL提高
胡世雄[38] 中国 胃癌 评价全胃切除空肠移置代胃人工幽门括约肌重建术的远期QOL 106例 Viscik's改进评分法(普适性) QOL优良率为89.6%,QOL改善
Ishihara[39] 日本 胃癌 胃癌术后远期QOL 51例 QLI(普适性) 远期QOL改善

"

第一作者 国家 诊断 研究内容 病例数 QOL量表(类型) 评价结果
Glimelius[40] 瑞典 进展期胃癌 ELF方案联合最佳支持治疗是否优于单纯支持治疗 61例 QLQ-C30(普适性) 化疗+最佳支持治疗QOL改善
Eguchi[41] 日本 胃癌 多西他赛+5-FU对QOL的影响 5例 QLQ-C30(普适性) QOL明显提高
Nakano[42] 日本 胃癌 评价香菇多糖对生存期及QOL的影响 45例 自制胃癌量表(特异性) 香菇多糖可以提高QOL
Sadighi [43] 伊朗 进展期胃癌 比较TCF方案和ECF方案对QOL的影响 71例 QLQ-C30(普适性) TCF方案在QOL方面显示出优越性
Wadler[44] 美国 晚期胃癌 评估FHIG方案和AD方案对QOL的影响 29例 FACT-F(普适性) 二者对QOL影响无显著差异
[1] Vickery CW, Blazeby JM, Conroy T , et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer[J]. Eur J Cancer, 2001,37(8):966-971
doi: 10.1016/S0959-8049(00)00417-2
[2] Liu JL, Zhong T, Liang CY . Quality of life scale selection strategies[J]. Sichuan Yi Xue, 2006,27(7):675-676
doi: 10.3969/j.issn.1004-0501.2006.07.007
刘加林, 钟涛, 梁传余 . 生存质量量表选择的策略[J]. 四川医学, 2006,27(7):675-676
doi: 10.3969/j.issn.1004-0501.2006.07.007
[3] Men BY, Li F, Gao HY . Clinical prospective efficacy and prognostic estimation method for malignant tumor(part two): Quality of life survey[J]. Xian Dai Zhong Liu Yi Xue, 2003,11(3):161-163
门伯媛, 李汾, 高海燕 . 恶性肿瘤临床远期疗效评价及预后的估计方法(二)——生存质量测评[J]. 现代肿瘤医学, 2003,11(3):161-163
[4] Bergner M, Bobbitt RA, Carter WB , et al. The Sickness Impact Profile: development and final revision of a health status measure[J]. Med Care, 1981,19(8):787-805
doi: 10.1097/00005650-198108000-00001 pmid: 7278416
[5] Spitzer WO, Dobson AJ, Hall J , et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians[J]. J Chronic Dis, 1981,34(12):585-597
doi: 10.1016/0021-9681(81)90058-8
[6] Schipper H, Clinch J , McMurray A, et al.Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation[J]. J Clin Oncol, 1984,2(5):472-483
doi: 10.1200/JCO.1984.2.5.472
[7] Eypasch E, Williams JI, Wood-Dauphinee S , et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument[J]. Br J Surg, 1995,82(2):216-222
doi: 10.1002/(ISSN)1365-2168
[8] Aaronson NK, Ahmedzai S, Bergman B , et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993,85(5):365-376
doi: 10.1093/jnci/85.5.365
[9] Jiang BF, Liu CX, Cui YC . Reliability and validity for Chinese version of QLQ-C30[J]. Zhongguo Lin Chuang Xin Li Xue Za Zhi, 2005,13(1):31-32, 36
姜宝法, 刘春晓, 崔永春 . EORTC QLQ-C30的信度、效度研究[J]. 中国临床心理学杂志, 2005,13(1):31-32, 36
[10] Tan SS, Li H, Luo J , et al. Assessment on the standard Chinese version of the Quality of Life Score Questionnaire Version 3.0 designed by European Organization for Research and Treatment of Cancer[J]. Zhongguo Lin Chuang Kang Fu, 2006,10(4):23-27
谭诗生, 李杭, 罗健 , 等. 欧洲癌症研究与治疗组织研制的生活质量核心调查问卷第3版中文版生活质量调查问卷测评[J]. 中国临床康复, 2006,10(4):23-27
[11] Bonomi AE , Cella DF.Cross-cultural adaptation of the Functional Assessment of Cancer Therapy( FACT) measurement system for use in European oncology clinical trials[J].Qual Life Newsl, 1995, 12: 5-7
[12] Cella DF, Tulsky DS, Gray G , et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure[J]. J Clin Oncol, 1993,11(3):570-579
doi: 10.1200/JCO.1993.11.3.570
[13] Wan CH, Meng Q, Tang XL , et al. Evaluation of Chinese version of the FACT-G scale for patients with cancer[J]. Shi Yong Zhong Liu Za Zhi, 2006,21(1):77-80
doi: 10.3969/j.issn.1001-1692.2006.01.027
万崇华, 孟琼, 汤学良 , 等. 癌症患者生命质量测定量表FACT-G中文版评价[J]. 实用肿瘤杂志, 2006,21(1):77-80
doi: 10.3969/j.issn.1001-1692.2006.01.027
[14] Luo J, Sun Y, Zhou SY . Development of quality of life questionnaire for Chinese cancer patients receiving chemobiotherapy[J]. Zhonghua Zhong Liu Za Zhi, 1997,19(6):437-441
罗健, 孙燕, 周生余 . 中国癌症患者化学生物治疗生活质量量表的编制[J]. 中华肿瘤杂志, 1997,19(6):437-441
[15] Wan CH, Luo JH, Yang Z , et al. Development of the general module of the system of quality of life instruments for cancer patients: responsiveness analysis[J]. Ai Zheng, 2007,26(4):337-340
万崇华, 罗家洪, 杨铮 , 等. 癌症患者生命质量测定量表体系共性模块的研制(三): 反应度分析[J]. 癌症, 2007,26(4):337-340
[16] Liu FA, Yu SY . Development of quality of life questionnaire for cancer patients QLQ-52 and the evaluation of questionnaire's quality[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2005,10(3):235-239
刘福安, 于世英 . 癌症患者生活质量评估量表QLQ-52的设计及质量评价[J]. 临床肿瘤学杂志, 2005,10(3):235-239
[17] Blazeby JM, Conroy T, Bottomley A , et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer[J]. Eur J Cancer, 2004,40(15):2260-2268
doi: 10.1016/j.ejca.2004.05.023
[18] Jiang BF, Xu T, Liu CX , et al. Development of Chinese version of QLQ-STO 22[J]. Zhongguo Xin Li Wei Sheng Za Zhi, 2005,19(5):310-312
doi: 10.3321/j.issn:1000-6729.2005.05.005
姜宝法, 徐涛, 刘春晓 , 等. 胃癌患者生活质量问卷(QLQ-STO 22)中文版的制定[J]. 中国心理卫生杂志, 2005,19(5):310-312
doi: 10.3321/j.issn:1000-6729.2005.05.005
[19] Troidl H, Kusche J, Vestweber KH , et al. Quality of life: an important endpoint both in surgical practice and research[J]. J Chronic Dis, 1987,40(6):523-528
doi: 10.1016/0021-9681(87)90009-9 pmid: 3298294
[20] Wu CW, Hsieh MC, Lo SS , et al. Quality of life of patients with gastric adenocacinoma after curative gastrectomy[J]. World J Surg, 1997,21(7):777-782
doi: 10.1007/s002689900305 pmid: 9276711
[21] Thybusch-Bernhardt A, Schmidt C, Küchler T , et al. Quality of life following radical surgical treatment of gastric carcinoma[J]. World J Surg, 1999,23(5):503-508
doi: 10.1007/PL00012339 pmid: 10085401
[22] Meng X, Tian J . Analysis on the influential factors for the quality of life of patients with gastric carcinoma by cumulative odds logistic regression[J]. Zhongguo Man Xing Ji Bing Yu Fang Yu Kong Zhi, 2003,11(2):51-53
孟欣, 田俊 . 胃癌患者生存质量影响因素的累积比数模型分析[J]. 中国慢性疾病预防与控制, 2003,11(2):51-53
[23] Wan CH, Luo JH, Zhang CZ , et al. Research of scale system on quality of life for patients with cancer[J]. Zhongguo Xing Wei Yi Xue Ke Xue, 2003,12(3):341-342
万崇华, 罗家洪, 张灿珍 , 等. 癌症患者生命质量测定量表体系研究[J]. 中国行为医学科学, 2003,12(3):341-342
[24] Gockel I, Pietzka S, Junginger T . Quality of life after subtotal resection and gastrectomy for gastric cancer[J]. Chirurq, 2005,76(3):250-257
doi: 10.1007/s00104-004-0950-5
[25] Hoksch B, Ablassmaier B, Zieren J , et al. Quality of life after gastrectomy: Longmire's reconstruction alone compared with additional pouch reconstruction[J]. World J Surg, 2002,26(3):335-341
doi: 10.1007/s00268-001-0229-7
[26] Horvth OP, Kalmar K, Cseke L , et al. Nutritional and life-quality consequences of aboral pouch construction after total gastrectomy: a randomized, controlled study[J]. Eur J Surg Oncol, 2001,27(6):558-563
doi: 10.1053/ejso.2001.1172
[27] Huang CC, Lien HH, Wang PC , et al. Quality of life in disease-free gastric adenocarcinoma survivors: impacts of clinical stages and reconstructive surgical procedures[J]. Dig Surg, 2007,24(1):59-65
doi: 10.1159/000100920
[28] Bae JM, Kim S, Kim YW , et al. Health-related quality of life among disease-free stomach cancer survivors in Korea[J]. Qual Life Res, 2006,15(10):1587-1596
doi: 10.1007/s11136-006-9000-8 pmid: 17036253
[29] Liu TC, Zhan WH, Wang JP , et al. Study of quality of life on patients with gastric cancer after curative dissection[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2002,5(1):20-23
doi: 10.3760/cma.j.issn.1671-0274.2002.01.005
刘统成, 詹文华, 汪建平 , 等. 胃癌根治术后患者生活质量的研究[J]. 中华胃肠外科杂志, 2002,5(1):20-23
doi: 10.3760/cma.j.issn.1671-0274.2002.01.005
[30] Ma ZS, Dong MF, Qiao YZ , et al. Quality of life after subtotal resection and total gastrectomy for gastric cancer of phase Ⅲ[J]. Ai Zheng, 2001,20(10):1008
doi: 10.3321/j.issn:1000-467X.2001.10.026
马增山, 董铭峰, 乔以泽 , 等. Ⅲ期贲门癌胃次全切除与全胃切除术后生存质量的比较[J]. 癌症, 2001,20(10):1008
doi: 10.3321/j.issn:1000-467X.2001.10.026
[31] Kono K, Iizuka H, Sekikawa T , et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy[J]. Am J Surg, 2003,185(2):150-154
doi: 10.1016/S0002-9610(02)01211-4 pmid: 12559446
[32] Shiraishi N, Adachi Y, Kitano S , et al. Clinical outcome of proximal versus total gastrectomy for proximal gastric cancer[J]. World J Surg, 2002,26(9):1150-1154
doi: 10.1007/s00268-002-6369-6 pmid: 12209245
[33] McCulloch P, Ward J, Tekkis PP , et al. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study[J]. BMJ, 2003,327(7425):1192-1197
doi: 10.1136/bmj.327.7425.1192
[34] Chau I, Norman AR, Cunningham D , et al. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data[J]. J Clin Oncol, 2004,22(12):2395-2403
doi: 10.1200/JCO.2004.08.154
[35] Díaz De Liao A, Oteiza Martínez F, Ciga MA , et al. Impact of surgical procedure for gastric cancer on quality of life[J]. Br J Surg, 2003,90(1):91-94
doi: 10.1002/bjs.4011 pmid: 12520582
[36] Blazeby JM, Metcalfe C, Nicklin J , et al. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia[J]. Br J Surg, 2005,92(12):1502-1507
doi: 10.1002/(ISSN)1365-2168
[37] Chen YP, Yang JS, Chen K , et al. A study on quality of life in long-term survivors following surgery for cardia cancer[J]. Zhongguo Zhong Liu, 2004,13(4):215-217
doi: 10.3969/j.issn.1004-0242.2004.04.006
陈于平, 杨捷生, 陈葵 , 等. 贲门腺癌切除术后远期生存质量观察[J]. 中国肿瘤, 2004,13(4):215-217
doi: 10.3969/j.issn.1004-0242.2004.04.006
[38] Hu SX, Guo LY, Wu YA , et al. To assess long-term outcome of total gastrectomy with grafting jejunum for gastric and pyloric reconstruction in patients with gastric cancer[J]. Lin Chuang Jun Yi Za Zhi, 2007,35(1):21-23
doi: 10.3969/j.issn.1671-3826.2007.01.008
胡世雄, 郭凌燕, 吴印爱 , 等. 全胃切除空肠移置代胃人工幽门括约肌重建术治疗胃癌的远期疗效评价[J]. 临床军医杂志, 2007,35(1):21-23
doi: 10.3969/j.issn.1671-3826.2007.01.008
[39] Ishihara K . Long-term quality of life in patients after total gastrectomy[J]. Cancer Nurs, 1999,22(3):220-227
doi: 10.1097/00002820-199906000-00005 pmid: 10376383
[40] Glimelius B , Ekstrm K, Hoffman K, et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer[J]. Ann Oncol, 1997,8(2):163-168
doi: 10.1023/A:1008243606668
[41] Eguchi T, Fujii M, Wakabayashi K , et al. Docetaxel plus 5-fluorouracil for terminal gastric cancer patients with peritoneal dissemination[J]. Hepatogastroenterology, 2003,50(53):1735-1738
[42] Nakano H, Namatame K, Nemoto H , et al. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group[J]. Hepatogastroenterology, 1999,46(28):2662-2668
[43] Sadighi S, Mohagheghi MA, Montazeri A , et al. Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU(TCF) with epirubicin, cisplatin, 5-FU(ECF)[J]. BMC Cancer, 2006,6(11):274
doi: 10.1186/1471-2407-6-274
[44] Wadler S, Brain C, Catalano P , et al. Randomized phase Ⅱ trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296[J]. Cancer J, 2002,8(3):282-286
doi: 10.1097/00130404-200205000-00013
[45] Li SF, He L, Song YG . Clinical observation on Yiqi Huoxue herbs combined with EAP therapy in improving quality of life in patients with advanced gastric cancer[J]. Sichuan Zhong Yi, 2002,20(12):33-34
李淑芳, 贺磊, 宋炎阁 . 益气活血中药联合EAP方案改善晚期胃癌患者生存质量的临床观察[J]. 四川中医, 2002,20(12):33-34
[46] Chen P, Wang HJ, Zhu L , et al. The rudiment assessment for the correlation factors of the quality of life in gastrointestinal cancer patients[J]. Xinjiang Yi Ke Da Xue Xue Bao, 2005,28(11):1029-1032
陈鹏, 王海江, 朱琳 , 等. 影响胃肠道肿瘤患者生命质量相关因素的初步评价[J]. 新疆医科大学学报, 2005,28(11):1029-1032
[47] Jiang Y, Hua HX, Lu HF , et al. Investigations of psycho-problems and contrast studies of psycho- intervention in postoperative patients with gastric carcinoma[J]. Lin Chuang Xin Shen Ji Bing Za Zhi, 2006,12(1):39-41
蒋颖, 华红霞, 卢回芬 , 等. 胃癌术后患者心理问题调查与心理干预对照研究[J]. 临床心身疾病杂志, 2006,12(1):39-41
[48] Liu J, Nie YZ . Assessment of quality of life in patients with gastric cancer[J]. Xian Dai Kang Fu, 2001,5(12):22-23, 26
刘军, 聂勇战 . 胃癌患者生存质量的评估[J]. 现代康复, 2001,5(12):22-23, 26
[1] Long Liu, Ling Xu, Da-zhi Sun, Pin-kang Wei. Establishment of a fuzzy mathematical model for syndrome differentiation of gastric cancer. Journal of Chinese Integrative Medicine, 2008, 6(11): 1117-1121.
[2] Bao-mu Sun, Ming Luo, Sheng-bing Wu, Xiao-xia Chen. Jinlong Capsule combined with transarterial chemoembolization in treatment of gastric cancer with liver metastasis. Journal of Chinese Integrative Medicine, 2008, 6(9): 968-970.
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40.
[4] Li Tao, Jin-kun Yang. Multifactor analysis of syndrome differentiation in traditional Chinese medicine and clinical correlative factors in gastric cancer. Journal of Chinese Integrative Medicine, 2007, 5(5): 510-513.
[5] Xiao-dong Guo, Pin-kang Wei. Effect of Xiaotan Sanjie Recipe on growth of transplanted tumor and expressions of proliferating cell nuclear antigen and epidermal growth factor receptor in tissue of gastric carcinoma of nude mice. Journal of Chinese Integrative Medicine, 2007, 5(4): 432-436.
[6] Li Tao, Jin-kun Yang. Univariate analysis of syndrome differentiation in traditional Chinese medicine and clinical correlative factors in gastric cancer. Journal of Chinese Integrative Medicine, 2007, 5(4): 398-402.
[7] Jin-shui Zhu, Ming-quan Song, Long Wang, Qun Sun, Li Zhu, Chun Fang. Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients. Journal of Chinese Integrative Medicine, 2006, 4(5): 478-481.
[8] Yan Xiao, Pin-kang Wei, Jun Li, Jun Shi, Zhi-hong Yu, Hui-ming Lin. Effects of Rhizoma kaempferiae volatile oil on tumor growth and cell cycle of MKN-45 human gastric cancer cells orthotopically transplanted in nude mice. Journal of Chinese Integrative Medicine, 2006, 4(4): 384-387.
[9] Zhi-hong Yu, Pin-kang Wei, Ling Xu, Zhi-feng Qin, Jun Shi, Yan Xiao, Hui-ming Lin. Effects of Jinlongshe Granules on apoptosis of MKN-45 human gastric cancer cells orthotopically transplanted in nude mice. Journal of Chinese Integrative Medicine, 2006, 4(3): 275-280.
[10] Ya-sheng Zhang​, Li-fei Zhu​, Xue-song Weng​. Clinical observation on treatment of gastric cancer with Zhijing Granules: A report of 148 cases. Journal of Chinese Integrative Medicine, 2006, 4(3): 315-317.
[11] Hai-lei Zhao, Ai-guang Zhao, Sheng-fu You, Ying Gu, Lai-di Tang, Jin-kun Yang. Growth-inhibiting and anti-metastasis effects of Weichang'an Decoction on orthotopic transplant nude mouse model of human gastric cancer. Journal of Chinese Integrative Medicine, 2005, 3(5): 378-381.
[12] Jun Cai, Zheng-rong Xuan, Yong-ping Wei, Hai-bo Yang, Hua Wang. Effects of perioperative administration of rhubarb on acute inflammatory response in patients with gastric cancer. Journal of Chinese Integrative Medicine, 2005, 3(3): 195-198.
[13] You-qi Xu, Hui-ning Xue, Xiao-qiu Zhu, Xiao-dong Chen. Clinical observation on treatment for postoperative metastasis of gastric cancer by Jianpi Huoxue Jiedu prescription. Journal of Chinese Integrative Medicine, 2003, 1(3): 192-194.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[2] Ji Chen, Qin Pan, Li-shuang Ye, Jia-ling Huang. English translation of cultural aspects of the titles of traditional Chinese medicine classics based on the skopos theory. Journal of Chinese Integrative Medicine, 2012, 10(11): 1316-1320
[3] Zhi-rong Zhu, Chang-chun Zeng, Li Yang, Han-ping Liu, Song-hao Liu. Influence of brightness value of supranasal point and apex nasi on dominant wavelength and excitation purity in complexion inspection of healthy adults. Journal of Chinese Integrative Medicine, 2011, 9(12): 1333-1338
[4] Samrat Ghosh, Sourav Sikdar, Avinaba Mukherjee, Anisur Rahman Khuda-Bukhsh. Evaluation of chemopreventive potentials of ethanolic extract of Ruta graveolens against A375 skin melanoma cells in vitro and induced skin cancer in mice in vivo. Journal of Integrative Medicine, 2015, 13(1): 34-44
[5] Arthur de Sá Ferreira, Antonio Guilherme Pacheco. SimTCM: A human patient simulator with application to diagnostic accuracy studies of Chinese medicine. Journal of Integrative Medicine, 2015, 13(1): 9-19
[6] Chuan-yue Niu. Methods of English translation for Huangdi Neijing. Journal of Chinese Integrative Medicine, 2005, 3(2): 160-163
[7] Han-jun Tang. Succession and innovation of Chinese traditional surgery: A perspective on the history. Journal of Chinese Integrative Medicine, 2005, 3(3): 169-173
[8] Wei Shan, Han-jun Tang, Chong-yu Zhang. Professor Tang Han-Jun's experience in treating postoperative fistulas. Journal of Chinese Integrative Medicine, 2005, 3(3): 235-237
[9] Bing He, Ge Zhang, Ai-ping Lu. Integrative network analysis: Bridging the gap between Western medicine and traditional Chinese medicine. Journal of Integrative Medicine, 2015, 13(3): 133-135
[10] Rodrigo Luiz Vancini, Marília dos Santos Andrade, Cássia Regina Vancini-Campanharo, Claudio Andre Barbosa de Lira. Concepts of biological rhythmicity and chronobiology in the Holy Bible. Journal of Integrative Medicine, 2015, 13(5): 279-280